Skip to main content
. 2022 Aug 5;2022:4782361. doi: 10.1155/2022/4782361

Figure 2.

Figure 2

SBF2-AS1 represses the survival of VSMCs in vitro. (a–f) The VSMCs were treated with exosomes derived from BMSCs transfected with overexpressing plasmid or SBF2-AS1 shRNA. (a) The cell viability was detected by CCK-8 assays. (b and c) The cell proliferation was tested by Edu assays. (d and e) The cell apoptosis was determined by TUNEL assays. (f) The caspase-3 activity was analyzed by the caspase-3 Activity Assay Kit. All experiments were performed in triplicate. ∗∗ indicated P < 0.01.